HIV activist Solly Nduku was recently elected to the top civil society position at SANAC. Thabo Molelekwa asked Nduku and his newly elected deputies about their plans and priorities for the council.
Hillbrow started out as Johannesburg’s first health hub in the late 1880s. It’s also been a suburb associated with pimps and prostitution, a middle finger to the Nationalist Party, and a key site of the HIV crisis. Today, it’s the forgotten flatlands of inner city decay … but in small pockets it stays true to its heritage of bringing healthcare to the city’s most overlooked.
Stopping antiretroviral treatment when you are living with HIV can result in increased HIV transmission, illness, hospitalisation, and eventually death. To combat such disengagement with HIV treatment, Professor Graeme Meintjes and colleagues argue we need smarter differentiated care and better education of healthcare workers, people living with HIV, and communities.
A Competition Commission probe recently resulted in a patent on an important tuberculosis medicine being dropped in South Africa. Twenty years ago, a similar Competition Commission case resulted in a settlement that helped drive down the prices of several antiretrovirals, thereby helping to set the stage for the country’s HIV treatment programme. Fatima Hassan and Leena Menghaney connect the dots between the two landmark cases and map out what has and has not changed over the last two decades.
Condom distribution in South Africa has dropped dramatically over the last five years, finds a Spotlight analysis of data recently published in the Health System Trust’s District Health Barometer.
The 11th South African AIDS Conference – the first since COVID-19-related disruptions – kicked off on Tuesday in Durban. This year’s theme is, “Act, Connect and End the Epidemic”. Spotlight summarises some key themes that emerged from the opening ceremony and spoke to some delegates.
The South African Health Products Regulatory Authority has authorised an injection containing the antiretroviral cabotegravir for use to prevent HIV infection, according to drugmaker ViiV Healthcare. Laura Lopez Gonzalez reports.
As we look at the year ahead, urgent work remains to build on past successes and to bring the HIV epidemic sustainably under control. Amongst others, we need to address persistent stigma and discrimination, as well as the structural and social factors that put women and girls at increased risk of HIV infection, argues Rachel Toku-Appiah.
The AIDS2022 conference held recently in Montreal, Canada highlighted yet again the need for community activism and the importance of involving young people, writes Dr Yogan Pillay. He argues that the youth and communities must be engaged in the conceptualisation and writing of South Africa’s new AIDS plan, and young people and community-based organisations must have a central role in key aspects of its implementation.
New estimates of HIV in South Africa’s provinces were made public last week. This interactive table shows how South Africa’s nine provinces compare on the UNAIDS 90-90-90 targets.
While men account for only a third of South Africa’s roughly 200 000 new HIV infections in the year ending mid-2019, they account for more than half of the approximately 74 000 HIV-related deaths in the same period. This is according to new estimates released on Tuesday from the Thembisa mathematical model of HIV in South Africa.
Timothy Lebelwane of Diepsloot is one of 2 000 people in South Africa participating in a COVID-19 vaccine trial spearheaded by Wits University. Biénne Huisman spoke to him about life as a participant in such an important vaccine trial.
